Results 61 to 70 of about 6,842,646 (288)
Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic‐guided prescribing over a traditional one‐size‐fits‐all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic‐informed care, or that ...
Lucy Galloway +2 more
wiley +1 more source
The profile of electronic cigarette users in Turkey
OBJECTIVE: Data on electronic cigarette (e-cigarette) use patterns are limited worldwide.
Aykut Topdemir +5 more
core +1 more source
Breaking point: Identifying the factors that predict suspension from school
Abstract School suspensions are associated with adverse educational and psychosocial outcomes, yet little is known about how structural disadvantage, relational factors, health behaviours, well‐being indicators and school‐level factors jointly predict suspension risk in England.
Stephanie Cahill +5 more
wiley +1 more source
Background Electronic cigarette consumption has increased worldwide. In Latin America, multiple gaps exist regarding health policies on manufacturing and restriction of electronic cigarette use.
Esperanza Figueroa-Hurtado +4 more
doaj +1 more source
Attempt to quit smoking by electronic cigarette use among smoking adolescents in Korea
Background Adolescent smoking has remained a major challenge. With strengthening of tobacco control policy, smoking rates have consistently declined over the past decade.
Sung Il Cho, Eunu Yuk
core +1 more source
ABUSE LIABILITY OF AN ELECTRONIC CIGARETTE IN TRADITIONAL CIGARETTE SMOKERS [PDF]
Electronic cigarettes have grown in popularity across the U.S. and concerns have been raised about their abuse liability. The purpose of the current study was to evaluate and compare the abuse liability of an electronic cigarette with and without ...
Maloney, Sarah F
core +1 more source
Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit +6 more
wiley +1 more source
Background Very little is known about the prices of new non-combustible tobacco products such as electronic cigarettes. Moreover, because of this paucity of data, it is difficult to evaluate the cost for individuals to use e-cigarettes and similar ...
Michal Stoklosa +4 more
core +1 more source

